2133417-13-5 (Ralmitaront,Ralmitaront)

5-乙基-4-甲基-N-[4-(2S)-2-吗啉基苯基]-1H-吡唑-3-甲酰胺;

Ralmitaront;RG7906;RG-7906;RG 7906;QA8MW1Q80P;Ralmitaront [INN];Ralmitaront [USAN];Ralmitaront (USAN/INN);WHO 11130;RO6889450;D11830;1H-Pyrazole-3-carboxamide, 5-ethyl-4-methyl-N-(4-(2S)-2-morpholinylphenyl)-;(s)-5-ethyl-4-methyl-n-(4-(morpholin-2-yl)phenyl)-1h-pyrazole-3-carboxamide;Ralmitaront [USAN:INN];2133417-13-5;DTXSID901336976;CHEMBL4594376;CS-0116071;HY-109157;GTPL12190;5-Ethyl-4-methyl-N-{4-[(2S)-morpholin-2-yl]phenyl}-1H-pyrazole-3-carboxamide;RALMITARONT [WHO-DD];1H-Pyrazole-3-carboxamide, 5-ethyl-4-methyl-N-[4-(2S)-2-morpholinylphenyl]-;Example 1 [WO2017157873A1];DA-67109;G17835;5-ethyl-4-methyl-~{N}-[4-[(2~{S})-morpholin-2-yl]phenyl]-1~{H}-pyrazole-3-carboxamide;UNII-QA8MW1Q80P;EX-A5232;MS-24620;RO-6889450;AKOS040759709;SCHEMBL19356836;UJU;5-Ethyl-4-methyl-N-[4-[(2S)-morpholin-2-yl]phenyl]-1H-pyrazole-3-carboxamide;

XHHXGKRFUPEPFM-OAHLLOKOSA-N

1S/C17H22N4O2/c1-3-14-11(2)16(21-20-14)17(22)19-13-6-4-12(5-7-13)15-10-18-8-9-23-15/h4-7,15,18H,3,8-10H2,1-2H3,(H,19,22)(H,20,21)/t15-/m1/s1

O1C([H])([H])C([H])([H])N([H])C([H])([H])[C@]1([H])C1C([H])=C([H])C(=C([H])C=1[H])N([H])C(C1C(C([H])([H])[H])=C(C([H])([H])C([H])([H])[H])N([H])N=1)=O